ALA
-
Launch of BioLynx provides a boost for the international malaria research community
New NUS spin-off company launches at TechVenture 2011.
ALA | 12 October 2011
-
Bristol-Myers Squibb and Saladax Biomedical expand collaboration for diagnostic assays for Alzheimer’s disease
Companies will collaborate globally on the development and regulatory approvals for certain diagnostic assays.
ALA | 20 September 2011
-
iBio announces malaria vaccine milestone achievement
iBio Inc announced successful animal testing of a malaria vaccine candidate produced using its proprietary iBioLaunch platform and sponsored by the Bill & Melinda Gates Foundation. Results were published in the August issue of the peer-reviewed, scie…
ALA | 05 August 2011
-
Novartis receives approval in Japan for Onbrez inhalation capsules
Novartis announced that it has received regulatory approval in Japan for Onbrez inhalation capsules (indacaterol) 150 mcg once-daily for the treatment of chronic obstructive pulmonary disease (COPD). Onbrez is said to be the only once-daily COPD ther…
ALA | 01 July 2011
-
Sanofi-aventis and Medicines for Malaria Venture join forces
Sanofi-aventis and Medicines for Malaria Venture (MMV) announced that they have signed an alliance agreement to research malaria treatments as well as the first research project agreement within the framework of the alliance. As part of the agreem…
ALA | 05 May 2011
-
Clinical trial for Ectoin inhalation solution
bitop is putting the first patient into a clinical trial on the Ectoin inhalation solution in patients with inflammation and airway obstruction. The present clinical study is a single-center efficacy and feasibility study involving patients with …
ALA | 30 December 2010
-
Multi-ethnic human genome study of Malaysian population
Malaysian Genomics Resource Centre ( MGRC ) is commencing two genome sequencing and analysis projects awarded by the country’s Ministry of Science, Technology and innovation (MOSTI). The two projects are the first of their respective kind in Mal…
ALA | 29 December 2010
-
SIgN and Novartis discover effective malaria drug
Scientists from the Singapore Immunology Network (SIgN) led by Dr Laurent Renia have made breakthrough on a drug that is effective against malaria. Their work, carried out with Novartis, Swiss Tropical and Public Health Institute, and Scripps Resear…
ALA | 01 October 2010
-
Immunization for malaria and Buruli ulcer
Telormedix is collaborating with the Swiss Tropical and Public Health Institute (Swiss TPH) on a pilot study using Telormedix’s adjuvant, TMX-201, in connection with immunization for Malaria and Buruli Ulcer. TMX-201 is a second generation TLR7…
ALA | 14 September 2010
-
Treating hearing loss and balance disorders
GenVec announces a new agreement for the supply of services relating to development materials with Novartis, related to the companies' collaboration in hearing loss and balance disorders. Under this new agreement, GenVec could receive approximately …
ALA | 30 August 2010
